Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOPIC #355 - SBIR PHASE II - A 3D PERFUSABLE PLATFORM FOR HTS ACROSS DIVERSE RACIAL/ETHNIC CANCER SPE | MIMETAS US INC. | $2,000,000 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | Sep 16, 2019 | Sep 16, 2019 | Sep 15, 2022 | ||
| IGF::OT::IGF DEVELOPMENT AND EVALUATION OF THE HEPAPLATE IPS: A HIGH THROUGHPUT ORGAN-ON-ACHIP IPS HEPATOTOXICTY SCREENING PLATFORM | MIMETAS US INC. | $1,500,000 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | Feb 8, 2018 | Feb 8, 2018 | Aug 14, 2020 | ||
| IGF::OT::IGF SBIR TOPIC 355: A 3D PERFUSABLE PLATFORM FOR HTS ACROSS DIVERSE RACIAL/ETHNIC CANCER SPECIMENS TO GENERATE RACIALLY DIVERSE PATIENT-DERIVED XENOGRAFT (PDX)-DERIVED PROSTATE CANCER CULTURES IN MIMETAS 3D ONCOPLATE HIGH-THROUGHPUT PLATFORM CONTAINING 96 EX VIVO MICRO TUMORS. | MIMETAS US INC. | $297,962 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541711 | Q301MEDICAL- LABORATORY TESTING | Sep 18, 2017 | Sep 19, 2017 | Jun 18, 2018 | ||
| IGF::OT::IGF DEVELOPMENT AND EVALUATION OF THE HEPAPLATE IPS: A HIGH THROUGHPUT ORGAN ON A CHIP IPS HEPATOTOXICTY SCREENING PLATFORM | MIMETAS US INC. | $224,998 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541712 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | May 12, 2016 | May 12, 2016 | May 14, 2017 |